Helsinn Healthcare S.A.: Helsinn Collaborates with Lyfebulb to Support Patient-Driven Innovations for People with Cancer
March 21, 2017 08:00 ET
|
Helsinn Healthcare S.A.
Helsinn Collaborates with Lyfebulb to Support Patient-Driven Innovations for People with Cancer Lugano, Switzerland and New York, NY, March 21, 2017 - Helsinn, a Swiss pharmaceutical group...
Helsinn Provides Grant for ESMO's Preceptorship Course on Supportive and Palliative Care
February 15, 2017 03:10 ET
|
Helsinn Healthcare S.A.
Helsinn Provides Grant for ESMO's Preceptorship Course on Supportive and Palliative Care Lugano, Switzerland, February 15, 2017 - Helsinn, a Swiss pharmaceutical group focused on building quality...
Helsinn Healthcare S.A.: Mundipharma and Helsinn Group Expand Exclusive Licensing and Distribution Agreements for Leading Anti-emetic Products in Middle East, Africa, Latin America and Indonesia
February 14, 2017 04:00 ET
|
Helsinn Healthcare S.A.
Mundipharma and Helsinn Group Expand Exclusive Licensing and Distribution Agreements for Leading Anti-emetic Products in Middle East, Africa, Latin America and Indonesia Anti-emetic products...
Helsinn Healthcare S.A.: Helsinn Group Launches "Helsinn Cares" Patient Support Services in the US
February 13, 2017 10:33 ET
|
Helsinn Healthcare S.A.
Helsinn Group Launches "Helsinn Cares" Patient Support Services in the US Patient Assistance Program and Voucher Program will support both insured and uninsured patients in the United States...